Figure 3 | Scientific Reports

Figure 3

From: Development and validation of a decision model for the evaluation of novel lung cancer treatments in the Netherlands

Figure 3

Jitter plot comparing modelled and observed progression-free survival (PFS) and overall survival (OS) probabilities. (a and b), PFS and OS from the start of first-line treatment (1L); (c) and (d), PFS and OS from the start of second-line treatment (2L); (e), OS from the start of third-line treatment (3L). The red dots (modelled) refer to the simulated values for a non-personalized treatment strategy where simulated patients are treated with a first-line platinum-based chemotherapy as in the template dataset. The black dots with 95% C.I indicate the point estimates and 95% confidence intervals of observed probabilities from the template dataset (Santeon registry 2008–2014).

Back to article page